Effect of naltrexone on weight gain and food craving induced by tricyclic antidepressants and lithium: An open study

Biological Psychiatry

Volumn 41, Issue 6, 1997, Pages 747-749

  Zimmermann, Ulrich ^a,b   Rechlin, Thomas ^a   Plaskacewicz, Gregor J ^a   Barocka, Arnd ^a   Wildt, Ludwig ^a   Kaschka, Wolfgang P ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

antidepressants; endogenous opiates; food craving; lithium; naltrexone; weight gain

Indexed keywords

AMITRIPTYLINE; DOXEPIN; IMIPRAMINE; LITHIUM; MAPROTILINE; NALTREXONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DYSTHYMIA; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; WEIGHT GAIN;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; APPETITE; DEPRESSIVE DISORDER; FEMALE; HUMANS; LITHIUM; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PSYCHIATRIC STATUS RATING SCALES; WEIGHT GAIN;

EID: 0030965893     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00523-9     Document Type: Article

References (16)

1. Atkinson RL, Berke LK, Drake CR, Bibbs ML, Williams FL, Kaiser DL (1985): Effects of long-term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther 38:419-422.
2. Baptista T, Teneud L, Contreras Q, et al (1995): Lithium and body weight gain. Pharmacopsychiatry 28:35-44.
3. Bertino M, Beauchamp GK, Engelman K (1991): Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans. Am J Physiol 261:R59-R63.
4. Burns G, Herz A, Nikolarakis KE (1990): Stimulation of hypothalamic opioid peptide release by lithium is mediated by opioid autoreceptors: Evidence from a combined in vitro, ex vivo study. Neuroscience 36:691-697.
5. Caro JF, Kolaczynski JW, Nyce MR, et al (1996): Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 348:159-161.
6. Drewnowski A, Krahn DD, Demitrack DA, Nairn K, Gosnell BA (1992): Taste responses and preferences for sweet high-fat foods: Evidence for opioid involvement. Physiol Behav 51: 371-379.
7. Fernstrom MH, Kupfer DJ (1988): Imipramine treatment and preference for sweets. Appetite 10:149-155.
8. Garland EJ, Remick RA, Zis AP (1988): Weight gain with antidepressants and lithium. J Clin Psychopharmacol 8:323-330.
9. Jonas JM, Gold MS (1987): The use of opiate antagonists in treating bulimia: A study of low-dose versus high-dose naltrexone. Psychiatry Res 24:195-199.
10. Leibowitz SF (1992): Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. Trends in Neurosciences 15:491-497.
11. Levine AS, Billington CJ (1989): Opioids. Are they regulators of feeding? Ann N Y Acad Sci 575:209-219.
12. Morley JE (1989): Appetite regulation: The role of peptides and hormones. J Endocrinol Invest 12:135-147.
13. Stunkard AJ, Messick S (1985): The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 29:71-83.
14. Valverde O, Mico JA, Maldonado R, Mellado M, Gibert-Rahola J (1994): Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain tests in mice. Prog Neuropsychopharmacol Biol Psychiatry 18:1073-1092.
15. Wahlström A, Lenhammar L, Ask B, Rane A (1994): Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation. Pharmacol Toxicol 75:23-27.
16. Yeomans MR, Wright P (1991): Lower pleasantness of palatable foods in nalmefene-treated human volunteers. Appetite 16: 249-259.